寶藿苷II
分析標準品,HPLC≥98%
Baohuoside II
CAS號：55395-07-8
分子式：C26H28O10
分子量：500.5
MDL：MFCD26406176
別名：大花淫羊藿苷A；意卡瑞苷A
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20076-5mg | 分析標準品,HPLC≥98% | ￥1300.00 | 現(xiàn)貨 |
YJ-B20076-20mg | 分析標準品,HPLC≥98% | ￥3580.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點：160℃
沸點：782.1±60.0 ℃
比旋光度：(c, 0.99 in Py)-79
外觀：黃色粉末
溶解性：可溶于甲醇、乙醇、DMSO等有機溶劑
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(7篇)
7. [IF=4.3] Yang Linlin et al."Spraying methyl jasmonate before harvesting can significantly increase the content of icariin in an important leaf medicinal herb, Epimedium sagittatum, by activating the expression of genes involved in flavonoid synthesis pathways."BMC
6. [IF=1.6] Liu Huimin et al."Identification and Characterization of the Chemical Constituents of Qianlie Shule Capsules by UPLC-Q-Orbitrap-MS/MS."JOURNAL OF AOAC INTERNATIONAL".2024 Feb;:
5. [IF=8.4] Ting An et al."De novo biosynthesis of anticarcinogenic icariin in engineered yeast."METABOLIC ENGINEERING.2023 Nov;80:207
4. [IF=6.208] Yu Yao et al."A Novel 3-O-rhamnoside: 2″-O-xylosyltransferase Responsible for Terminal Modification of Prenylflavonol Glycosides in Epimedium pubescens Maxim.."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(24):16050
3. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177
2. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137
1. Zhou, Jing, et al. "A strategy for rapid discovery of traceable chemical markers in herbal products using MZmine 2 data processing toolbox: A case of Jing Liqueur." Chinese Herbal Medicines (2021).
從2011年開始我們致力于在生命科學領(lǐng)域、生物醫(yī)學實驗技術(shù)及論文潤色服務，協(xié)助客戶各類實驗服務及論文潤色十多年，是您值得信賴的科研合作伙伴!
如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實驗技術(shù)服務：
| |||
| |||
| |||
| |||
| |||
|
